Maravai LifeScience Holdings Inc. (MRVI) Should Trade Up On Positive Partner Commentary - BofA Securities
Tweet Send to a Friend
BofA Securities analyst Michael Ryskin reiterated a Buy rating and $31.00 price target on Maravai LifeScience Holdings Inc. (NASDAQ: MRVI) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
